Revisiting the Role of NAG across the Continuum of Kidney Disease
Acute and chronic kidney diseases are an evolving continuum for which reliable biomarkers of early disease are lacking. The potential use of glycosidases, enzymes involved in carbohydrate metabolism, in kidney disease detection has been under investigation since the 1960s. N-acetyl-beta-D-glucosamin...
Main Authors: | Ruder Novak, Grgur Salai, Stela Hrkac, Ivana Kovacevic Vojtusek, Lovorka Grgurevic |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-04-01
|
Series: | Bioengineering |
Subjects: | |
Online Access: | https://www.mdpi.com/2306-5354/10/4/444 |
Similar Items
-
Comparing the Urinary Value of N-Acetyl-β-D-Glucosaminidase (NAG) and β2-Microglobulinuria (β2M) in Acute Kidney Damage in Children
by: Alireza Merrikhi, et al.
Published: (2013-06-01) -
Urinary Malondialdehyde (MDA) and N-Acetyl-β-D-Glucosaminidase (NAG) Associated with Exposure to Trichloroethylene (TCE) in Underground Water
by: Wen-Yu Lin, et al.
Published: (2022-05-01) -
Stage II of Chronic Kidney Disease—A Tipping Point in Disease Progression?
by: Lovorka Grgurevic, et al.
Published: (2022-06-01) -
Assessment of Subclinical Renal Glomerular and Tubular Dysfunction in Children with Beta Thalassemia Major
by: Asmaa A. Mahmoud, et al.
Published: (2021-02-01) -
First Characterization of ADAMTS-4 in Kidney Tissue and Plasma of Patients with Chronic Kidney Disease—A Potential Novel Diagnostic Indicator
by: Ivana Kovacevic Vojtusek, et al.
Published: (2022-03-01)